Impact of structurally modifying hyaluronic acid on CD44 interaction-Reference-Cited by-同舟云学术

Impact of structurally modifying hyaluronic acid on CD44 interaction

Published:2017 Issue:41 Volume:5 Page:8183-8192
ISSN:2050-750X
Container-title:J. Mater. Chem. B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Bhattacharya D. S.¹²³⁴^ORCID,Svechkarev D.¹²³⁴^ORCID,Souchek J. J.¹²³⁴^ORCID,Hill T. K.¹²³⁴^ORCID,Taylor M. A.⁵²³⁴^ORCID,Natarajan A.⁵²³⁴⁶^ORCID,Mohs A. M.¹²³⁴⁶^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences

2. University of Nebraska Medical Center

3. Omaha

4. USA

5. Eppley Institute for Research in Cancer and Allied Diseases

6. Fred and Pamela Buffett Cancer Center

Abstract

Deacetylation and sulfation of HA results in minimized binding with CD44.

Funder

National Institute of General Medical Sciences

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2017/TB/C7TB01895A

Reference70 articles.

1. Hyaluronan: Preparation, Structure, Properties, and Applications

2. Hyaluronan: from extracellular glue to pericellular cue

3. Hyaluronan in morphogenesis

4. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats.

5. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective Strategies in Designing Chitosan-hyaluronic Acid Nanocarriers: From Synthesis to Drug Delivery Towards Chemotherapy;Current Drug Delivery;2025-01

2. Hyaluronic acid mediated ZnO-NPs: In relation to electrical and photocatalytic activity for dye degradation;Journal of Alloys and Compounds;2024-11

3. Harnessing the CD44-targeted delivery of self-assembled hyaluronan nanogel to reverse the antagonism between Cisplatin and Gefitinib in NSCLC cancer therapy;Carbohydrate Polymers;2024-11

4. The use of “combined” approaches in ozone therapy. More chaffs than wheat;International Immunopharmacology;2024-10

5. Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges;Frontiers in Pharmacology;2024-08-06